Driving groundbreaking insights at the single-cell level, millions of times
Mass cytometry, powered by CyTOF® technology, is the world’s most advanced cytometric platform. It has opened new doors to discovery and clinical research by empowering investigators to interrogate more than 50 markers simultaneously on millions of individual cells. Join the hundreds who have reimagined cytometry with CyTOF to unveil new cell types, functions and biomarkers in immunology, cancer, infectious disease and more.
PUBLICATIONS TRENDING NOW
Explore these compilations of recent mass cytometry publications focused on specific areas of investigation.
March 2022: Maxpar Direct Immune Profiling Assay
January 2022: COVID-19 research update
November 2021: CAR T cells
July 2021: The value of high-parameter cytometry
April 2021: Immuno-oncology
January 2021: Cancer vaccine development
November 2020: Vaccines for infectious disease
July 2020: COVID-19 disease research